Brain scan study to finally test if low serotonin causes depression

NCT ID NCT07651293

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test the long-standing theory that depression is caused by low serotonin levels in the brain. Researchers will give a single dose of fenfluramine (a drug that releases serotonin) to 46 people—half with depression and half healthy—and use PET brain scans to measure serotonin release. The goal is to see if people with depression have a weaker serotonin response, which could help explain why some antidepressants work and others don't.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fenfluramine hydrochloride (a serotonin-releasing drug)
What this could lead to
If successful, this study could clarify whether serotonin deficiency plays a key role in depression and help identify who might benefit from SSRI antidepressants.
What could go wrong
This is a small, early-stage observational study (46 people) that does not test a new treatment. Fenfluramine is used only as a probe, not as a therapy. Results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • entre for Psychedelics Research, Division of Psychiatry Imperial College London, Level 2, Commonwealth Building, Hammersmith Campus, Du Cane Road, London

    London, W120NN, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.